Women's Health

DHA Hailed as Breakthrough Treatment for Lowering Risk of Developmental Disorders in Premature Infants; Animi-3(R) Prescribed to Women Who Are Not Eating Fish

Published in Women's Health Law Weekly, February 8th, 2009

Findings published in the Journal of the American Medical Association (JAMA) have demonstrated high doses of DHA-dominant omega-3 fatty acids administered to premature infants via their mother's breast milk can reduce the risk of developmental disorders.

In a six-year study involving 657 premature infants, researchers found the lipid DHA is not developed sufficiently in premature infants, leading to possible impaired mental development. To offset this omega-3 deficiency, 1000mg DHA supplements were given to lactating mothers with pre-term infants; some infants were fed supplemental infant formula with matching DHA levels.

Approximately 50 percent...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Law Weekly

Source: Women's Health Law Weekly (2009-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry